ARWR
Arrowhead Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +14.3% ·
aandelenstroom -0.7% ·
netto nieuwe posities +12.5%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 133 | +6 | 82.36M | $6.29B | +14 | −7 |
| Q1 2026 | 129 | +9 | 82.68M | $4.92B | +14 | −6 |
| Q4 2025 | 119 | +2 | 83.16M | $5.52B | +3 | — |
| Q3 2025 | 18 | 0 | 61.93M | $2.14B | +1 | −2 |
| Q2 2025 | 16 | +2 | 54.75M | $865.08M | +2 | — |
| Q1 2025 | 11 | +1 | 14.99M | $191.04M | +1 | — |
| Q4 2024 | 10 | -1 | 13.46M | $253.12M | +1 | −2 |
| Q3 2024 | 10 | +1 | 7.88M | $152.69M | +1 | — |
| Q2 2024 | 9 | — | 6.44M | $167.29M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 19.42M | — | $306.91M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 15.53M | — | $245.30M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 15.53M | — | $245.30M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 15.53M | — | $245.30M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 15.53M | — | $245.30M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 15.53M | — | $245.30M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passief) | 6.37M | -9.0% | $100.66M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 5.17M | — | $81.69M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 5.17M | — | $81.69M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 5.17M | — | $81.69M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 2.98M | +1.0% | $47.07M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 2.98M | +1.0% | $47.07M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Marshall Wace ✦ | 2.16M | +3507.8% | $34.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 30 | Marshall Wace ✦ | 2.16M | +3507.8% | $34.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 31 | Marshall Wace ✦ | 2.16M | +3507.8% | $34.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 32 | Norges Bank ✦ (passief) | 1.92M | +6.8% | $30.41M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Fisher Asset Management ✦ | 451.65K | -6.5% | $7.14M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Millennium Management ✦ | 169.04K | -75.5% | $2.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 152.35K | +276.1% | $2.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 152.35K | +276.1% | $2.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 152.35K | +276.1% | $2.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 152.35K | +276.1% | $2.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | Two Sigma Investments ✦ | 133.40K | -84.0% | $2.11M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | T. Rowe Price ✦ | 100.61K | +8.0% | $1.59M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 41 | Arrowstreet Capital ✦ | 64.20K | Nieuw | $1.01M | 0.0% | New | 1 | SEC ↗ |
| 42 | Citadel Advisors ✦ | 62.24K | -93.7% | $983,471 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | Wellington Management ✦ | 48.28K | -8.2% | $762,902 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | Wellington Management ✦ | 48.28K | -8.2% | $762,902 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 45 | Wellington Management ✦ | 48.28K | -8.2% | $762,902 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 46 | Wellington Management ✦ | 48.28K | -8.2% | $762,902 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 47 | Gotham Asset Management ✦ | 18.86K | Nieuw | $298,035 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Arrowstreet Capital | $1.01M | 0.0% |
| Gotham Asset Management | $298,035 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 7 houders, 11.03M aandelen, $23.90M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 2.00K aand · $173,920
Director · 11.60K aand · $1.01M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie